-
Chenodeoxycholic Acid: FXR Research Workflows
2026-09-04
Chenodeoxycholic Acid provides a practical chemical entry point for activating FXR in cholesterol metabolism research, liver function studies, and renal injury models. This workflow translates the reported FXR–KLF11 mechanism into formulation, cell-based, transcriptional, and troubleshooting strategies while separating established findings from optimization starting points.
-
HATU for Precise Peptide Coupling Workflows
2026-09-03
HATU streamlines carboxylic acid activation for challenging amide and ester formation, from peptide synthesis chemistry to medicinal chemistry libraries. This guide connects practical coupling conditions with the stereochemically defined inhibitor design reported for IRAP and related aminopeptidases.
-
Pertussis Toxin as a Causal Signaling Probe
2026-09-03
Pertussis toxin is more than an immune-modulating reagent: it is a causal probe for Gi/o-linked cAMP signaling. This article connects dendritic-cell assays with a 2024 mouse pharmacology study to show how pathway perturbation, receptor selectivity, and experimental controls should guide interpretation.
-
Cyclo (-RGDfC) for Integrin Targeting Workflows
2026-09-02
Cyclo (-RGDfC) converts αvβ3 integrin biology into practical adhesion, migration, angiogenesis, and targeted-delivery assays. Its cyclic c(RGDfC) scaffold supports receptor-focused experiments while the canine osteosarcoma reference study provides a useful framework for separating viability effects from mechanism-specific readouts.
-
CD38 CAR Binders: Structure-Guided Affinity Tuning
2026-09-02
This iScience study combines crystal structures, residue-level mutagenesis, enzymatic assays, and CAR-T functional testing to explain how RP02 and 028 engage CD38 differently. Its key contribution is a structure-guided affinity-tuning strategy in which an attenuated 028 variant reduced fratricide while preserving cytotoxicity against CD38-positive tumor cells.
-
HyperScribe T7 High Yield RNA Synthesis Kit Plus: Workflow
2026-09-01
The HyperScribe T7 High Yield RNA Synthesis Kit Plus combines high-yield T7 transcription with support for capped, dye-labeled, and biotinylated RNA formats. This workflow explains how to turn a linearized DNA template into research-grade RNA for mRNA rescue studies, RNA interference experiments, probe assays, and other demanding applications.
-
Nullscript: Histone Deacetylase Inhibitor Workflow
2026-09-01
Nullscript is a histone deacetylase inhibitor for separating HDAC blockade from transcriptional facilitation in cardiac, metabolic, and cell-based studies. Its scriptaid-like structure, inactive p6SBE-luc profile, and reported cardiac ischemia/reperfusion benefit make it especially useful for assay-first mechanism testing.
-
3X (DYKDDDDK) Peptide: FLAG Workflow Guide
2026-08-31
The 3X (DYKDDDDK) Peptide supports sensitive FLAG-tag capture, competitive elution, and orthogonal immunodetection in recombinant-protein workflows. This guide translates the MAZ–BCKDK–G6PD findings in triple-negative breast cancer into practical assay designs while addressing metal sensitivity, tag accessibility, and crystallization readiness.
-
Engineering a Simpler Bitespiramycin Producer
2026-08-31
The reference study used an in-frame partial deletion of sspA, encoding a 3-O-acyltransferase, to simplify the product profile of a recombinant bitespiramycin-producing Streptomyces strain. The resulting WSJ-2 strain was reported to produce predominantly 4″-isovalerylspiramycin I, illustrating how targeted pathway engineering can improve compositional control without redesigning the entire biosynthetic system.
-
HotStart Universal 2X Green qPCR Master Mix for NSCLC
2026-08-30
Translate the SPI1/miR-616-5p findings in NSCLC into a practical, specificity-first qPCR workflow. This guide shows how Green I fluorescence, hot-start Taq polymerase, ROX normalization, and melt curve analysis support reproducible gene expression quantification from cell and xenograft studies.
-
Veratridine for Chamber-Specific Cardiac Models
2026-08-29
Veratridine is more than a conventional neuroscience tool: its persistent sodium-channel activation offers a strategic stress test for chamber-specific human pluripotent stem cell-derived cardiomyocytes. This article connects the compound’s mechanism with recent right ventricular model development and outlines a translational workflow for electrophysiology, calcium handling, excitotoxicity studies, and sodium-channel blocker screening.
-
Dinaciclib, VHL Loss, and Selective CC-RCC Targeting
2026-08-28
The reference study identifies a synthetic-lethal relationship between Dinaciclib sensitivity and VHL deficiency in clear cell renal cell carcinoma (CC-RCC). Its integrated cell-based and orthotopic patient-derived xenograft experiments connect CDK inhibition with reduced Rb phosphorylation, MCL-1 loss, apoptosis, and activity against both CD105-positive cancer stem cells and CD105-negative tumor cells.
-
O6-Benzylguanine MGMT Inhibitor Workflows
2026-08-28
O6-Benzylguanine provides a direct pharmacological route to MGMT inhibition, helping researchers separate catalytic DNA repair failure from transcriptional regulation in alkylator-resistant cancer models. This practical guide connects formulation, combination dosing, MGMT activity inhibition assays, DNA-damage readouts, and troubleshooting to the AP-2α findings in recurrent glioma.
-
How Wnt Rewires Glycolysis in Bone Formation
2026-08-27
The reference study shows that Wnt3a promotes osteoblastogenesis by increasing O-GlcNAcylation through both rapid Ca2+-PKA-GFAT1 signaling and prolonged Wnt–β-catenin activity. O-GlcNAcylation stabilizes PDK1 at Ser174, redirects glucose metabolism toward aerobic glycolysis, and supports bone formation and fracture healing.
-
Bobcat339 for TET-Dependent DNA Methylation
2026-08-27
Bobcat339 provides a practical chemical perturbation for testing how TET1/TET2 activity influences DNA methylation, enhancer state, and gene transcription. Its strongest use-case is a staged workflow that connects biochemical inhibition with methylation, chromatin, and osteogenic readouts rather than relying on a single endpoint.